Physician profile
Michael J Smith
NPI 1750366076
$1,450.29
in general payments reported to CMS, 2019-2025
18 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $284 · 2021: $125 · 2022: $71.40 · 2023: $202 · 2024: $217 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Derma Sciences, INC. | $228.35 | 2019 | |
| Kerecis Limited | $192.77 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Zimmer Biomet Holdings, INC. | $167.76 | 2020-2024 | Comprehensive Shoulder System |
| Ferring Pharmaceuticals INC. | $134.95 | 2019-2022 | |
| Pacira Therapeutics, INC. | $107.91 | 2019-2021 | |
| Stryker Corporation | $107.25 | 2023-2025 | T2 Alpha, Mako |
| Encore Medical, Lp | $94.82 | 2020 | |
| Horizon Therapeutics Plc | $86.83 | 2019-2021 | |
| Depuy Synthes Sales INC. | $73.94 | 2021-2025 | |
| Revance Therapeutics, INC. | $52.49 | 2025 | Daxxify |
| Bioventus LLC | $35.22 | 2021 | |
| Mvp Orthopedics INC | $34.82 | 2022 | |
| Heraeus Medical, LLC. | $31.32 | 2023 | Palacos |
| Sanofi-Aventis U.S. LLC | $25.29 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $25.05 | 2023 | Zilretta, Iovera, Exparel |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $20.12 | 2024 | Hymovis |
| Electronic Waveform Lab, INC. | $17.13 | 2019 | |
| Sunovion Pharmaceuticals INC. | $14.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.